There
is a rising demand for low cost biological drugs. Commercial and regulatory
developments are taking the follow-on biologics market to new heights. Drug
manufacturers are exploring the possibilities of producing generic biopharmaceuticals
drugs with a motive of reducing the prices of these life saving drugs. However,
these possibilities are opposed by some scientific challenges and unanswered
questions.
Some
of the major factors driving the market are rising healthcare cost, expensive
drugs and the ageing population. The major challenges faced by the follow-on
biologics market are risk factors as it requires high investment and
possibilities of failure during the drug development stages. The growth
potential for biologics market is expected to be strong in the upcoming years
as patents for numerous second generation therapeutic proteins slated for
expiry between 2013 and 2019.
Browse the full report with request TOC at http://www.transparencymarketresearch.com/biosimilar-and-follow-on-biologics-market.html
Follow-on
Biologics Market Segmentation
Follow-on
biologics market is segmented based on the biologic drug classes as follows:
- Peptides
- Recombinant
Glycosylated Proteins
- Recombinant
Non-glycosylated Proteins
- Others
The
research report on follow-on biologics market analyzes the global market size,
and provides overview of market figures. It also studies the overall market growth
rate and current advancements in industry. This report analyzes current trends,
Porter’s five force analysis, and complete profiles of top industry players. It
also provides a detailed review of micro and macro factors essential for
existing market players and new entrants along with value chain analysis.
Major
geographies covered under this research report are North America, Europe,
Asia-Pacific and the Rest of the World.
The
key players dominating this market are 3SBio, Abbott, Abraxis BioScience,
Alexion Pharmaceuticals, Amphastar Pharmaceuticals, Astra Zeneca, Avesta
Biotherapeutics and Research (ABRPL), Avesthagen, Axicorp, Biogen Idec,
Bristol-Myers Squibb, CCL Pharmaceuticals, CinnaGen, Cipla, Dr. Reddy’s
Laboratories, Elan Corporation, Genentech, GlaxoSmithKline (GSK), Johnson &
Johnson, Mitsubishi Tanabe Pharma Corporation, Ranbaxy Laboratories, Sandoz,
Zenotech, and others.
This research report analyzes this market
depending on its market segments, major geographies, and current market trends.
Geographies analyzed under this research report include
- North
America
- Asia
Pacific
- Europe
- Rest of the
World
Read more reports of Pharmaceutical @ http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
This report
provides comprehensive analysis of
- Market
growth drivers
- Factors
limiting market growth
- Current
market trends
- Market
structure
- Market
projections for upcoming years
This
report is a complete study of current trends in the market, industry growth
drivers, and restraints. It provides market projections for the coming years.
It includes analysis of recent developments in technology, Porter’s five force
model analysis and detailed profiles of top industry players. The report also
includes a review of micro and macro factors essential for the existing market
players and new entrants along with detailed value chain analysis.
Reasons
for Buying this Report
- This report
provides pin-point analysis for changing competitive dynamics
- It provides
a forward looking perspective on different factors driving or restraining
market growth
- It provides
a technological growth map over time to understand the industry growth
rate
- It provides
a seven-year forecast assessed on the basis of how the market is predicted
to grow
- It helps in
understanding the key product segments and their future
·
It helps in
making informed business decisions by having complete insights of market and by
making in-depth analysis of market segments
Download PDF : Global Biosimilar and Follow-On Biologics Market
About
Us:-
Transparency Market Research (TMR) is
a market intelligence company providing global business research reports and
consulting services. Our exclusive blend of quantitative forecasting and trends
analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts,
researchers, and consultants use proprietary data sources along with various
tools and techniques to gather and analyze information. Our business offerings
represent the latest and the most reliable information which is indispensable
for businesses to sustain their competitive edge.
Our data repository is continuously
updated and revised by a team of research experts so that it always reflects
the latest trends and information. With broad research and analysis capability,
Transparency Market Research employs rigorous primary and secondary research
techniques in developing distinctive data sets and research material for
business reports.
Contact Us
Sheela
AK
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
Browse
More Market Reports:-
0 comments:
Post a Comment